Business

DIAGNOS has announced the launch of a pathology detection system at the retail clinic of Farmacias Benavides, a member of the Walgreens Boots Alliance of the Canadian Business Journal.

Brossard, Quebec, June 23, 2022 (GLOBE NEWSWIRE) — DIAGNOS Inc. (“”diagnoseLtd.“Or” we “) (TSX Venture: ADK) (OTCQB: DGNOF) Leader in early detection of serious health problems with the use of FLAIRE platform based on artificial intelligence (AI) Is pleased to announce the launch of a pathology detection system at the Walgreens Benavides retail clinic, a member of the Walgreens Boots Alliance.

“After signing the agreement between DIAGNOS and Farmacias Benavides announced in May, the efforts of our team in Mexico have already allowed the training of 30 doctors and a pathology detection system for 7 retail clinics.” I am saying. Guillermo Moreno Robles, Vice President of DIAGNOS.. “As we continue to work with Farmasias Benavides to deploy the system across our network of over 1,100 drugstores, the initial results show that each has a continuous and continuously growing revenue stream generated in this sector. I am confident that it will bring strong economic benefits. Organization “, Moreno Robles Conclusion.

As part of its efforts to help improve the quality of life of families and in line with its market share growth strategy, Farmasias Benavides is a leader in retail clinics by rapidly increasing the number of doctors’ locations. Occupy a position. We provide medical consultation. As a result, Mexicans can now get first-class medical care directly with real doctors at local pharmacies.

The flowering of retail clinics was boosted by a pandemic and a bill enacted by the Mexican health authorities supporting the opening of retail clinics. Currently, more than 10.6 million Mexicans are benefiting from this new outpatient care environment each month, according to COFE PRIS, the government committee responsible for regulating health-related topics in Mexico.

DIAGNOS President Andre Larente “The favorable conditions of the Mexican market and the fact that the pathological examination service is directly integrated into the chronic disease management program provided by Farmacias Benavides can contribute to our development and significantly increase the popularity of our service. Increasing awareness of the significant deterioration in quality of life that can occur if annual eye examinations are not performed. In addition, our services are from 8 am to 10 pm each year. Deployed in a number of retail stores that are open 24/7, pathology screening services will benefit from one of the best market access in the world. “

About Farmacias Benavides
Farmacias Benavides is the market leader in retail sales of health and wellness products in Mexico. With 104 years of experience, we are based in more than 197 cities in 24 states. They own a network of over 1,100 pharmacies, over 400 clinics, and high-tech distribution centers. The chain is run by more than 8,000 collaborators and offers a catalog of over 16,000 commercial and branded products focused on helping customers’ health and well-being.

Additional information is available at www.benavides.com.mx/.

About the Walgreens Boots Alliance (WBA)
The Walgreens Boots Alliance is a comprehensive leader in healthcare, pharmacy and retail, serving millions of customers and patients daily and has a 170-year community care tradition. With approximately 13,000 offices in the United States, Europe and Latin America, the WBA plays a key role in the healthcare ecosystem. WBA is shaping the future of healthcare by dispensing medicines, improving access to a wide range of healthcare services, providing quality health and beauty products, and providing convenient services anytime, anywhere across the digital platform.

Additional information available: www.walgreensbootsalliance.com/investors

About DIAGNOS
DIAGNOS is a Canadian listed company dedicated to early detection of critical health problems based on the FLAIRE Artificial Intelligence (AI) platform. FLAIRE allows you to quickly modify and develop applications such as CARA (Computer Assisted Retina Analysis). CARA’s image enhancement algorithm provides sharper, clearer, and easier-to-analyze retinal images. CARA is a cost-effective tool for real-time screening of large numbers of patients. CARA is licensed for commercialization by Health Canada, FDA (US), CE (Europe), COFEPRIS (Mexico), and Saudi FDA (Saudi Arabia) regulators.

Additional information at www.diagnos.com and www.sedar.com

This news release contains information about the future outlook. Actual results and future events may differ materially from those expected in these statements and there is no guarantee that the forward-looking information will be accurate. DIAGNOS disclaims any intention or obligation to publicly update or revise future outlook information as a result of new information, future events, etc. The forward-looking information contained in this news release is explicitly qualified by this notice.

Neither the TSX Venture Exchange nor its regulatory service provider (the term is defined in the TSX Venture Exchange Policy) is responsible for the validity or accuracy of this release.


CBJ News Maker

DIAGNOS has announced the launch of a pathology detection system at the retail clinic of Farmacias Benavides, a member of the Walgreens Boots Alliance of the Canadian Business Journal.

Source link DIAGNOS has announced the launch of a pathology detection system at the retail clinic of Farmacias Benavides, a member of the Walgreens Boots Alliance of the Canadian Business Journal.

Related Articles

Back to top button